9
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State

, , , , &
Pages 156-160 | Accepted 25 Oct 2013, Published online: 20 Jan 2016

References

  • Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5 (12): 939–51.
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21 (3): 538–82.
  • Tsakris A, Ikonomidis A, Poulou A et al. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect 2008; 14 (6): 588–94.
  • Sunenshine RH, Wright MO, Maragakis LL et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13 (1): 97–103.
  • Poirel L, Nordman P Carbapenem resistance in Acinetobacter baunannii: mechanism and epidemiology. Clin Microbiol Infect 2006; 12 (9): 826–36.
  • Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006; 57 (3): 373–83.
  • Mostachio AK, van der Heidjen IV, Rossi F, Levin AS, Costa SF. Multiplex PCR for rapid detection of genes encoding OXA and metallo-beta-lactamases in carbapenem resistant Acinetobacter spp. J Med Microbiol 2009; 58 (Pt 11):1552–4.
  • Seifert H, Dijkshoorn L, Gerner-Smidt P Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997; 35 (11): 2819–25.
  • Lone R, Shah A, Kadri SM, Lone S, Shah F. Nosocomial multi-drug-resistant Acinetobacter infections — clinical findings, risk factors and demographic characteristics. Bangladesh J Med Microbiol 2009; 3 (1): 34–8 (www.banglajol.info/index.php/BJMM/article/view/2969).
  • Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Guidelines for the collection, transport, processing, analysis and reporting of cultures from specific specimen sources. In: Color Atlas and Textbook of Diagnostic Microbiology 6th edn. Philadelphia: Lippincott, Williams and Wilkins, 2006: 68–105.
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement. CLSI Document M100-S20. Wayne, PA:CLSI, 2010.
  • Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamases producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40 (10): 3798–801.
  • Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double disk synergy test for differentiation of metallo-p-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41 (10): 4623–9.
  • Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-p-lactamases in routine clinical testing. J Clin Microbiol 2002; 40 (8): 2755–9.
  • Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51 (10): 3471–84.
  • Su CH, Wang JT, Hsiung CA et al. Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 2012; 7 (5): e37788.
  • Chu YW, Leung CM, Houang ET et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 1999; 37 (9): 2962–7.
  • Pandya NP, Prajapati SB, Mehta SJ, Kikani KM, Joshi PJ. Evaluation of various methods for MBL production in Gram-negative bacilli. Int J Biol Med Res 2011; 2 (3): 775–7.
  • Aybey AD, Aksit F, Oz Y, Kiremitci A, Durmaz G. Evaluation of an automated system for the detection of carbapenem-resistant Acinetobacter baumannii and assessment of metallo-p-lactamase production using two different phenotyping methods. J Microbiol Methods 2011; 86 (1): 121–3.
  • Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. Acinetobacter baumannii 2002–2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Resist 2010; 16 (3): 209–15.
  • Anupurba S, Sen MR. Antimicrobial resistance profile of bacterial isolates from intensive care unit: changing trends. J Commun Dis 2005; 37 (1): 58–65.
  • Koh TS, Sng LH, Wang GC, Hsu LY, Zhao Y. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 2007; 59 (4): 627–32.
  • Andriamanantena TS, Rastsima E, Rakotonirina HC et al. Dissemination of multidrug-resistant Acinetobacter baumannii in various hospitals in Antananarivo Madagascar. Ann Clin Microbiol Antimicrob 2010; 9: 17.
  • Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, 24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SEBTRY Surveillance Program. J Antimicrob Chemother 2009; 63 (1): 55–9.
  • Sung JY, Kwon KC, Park JW et al. Dissemination of IMP-1 and OXA type-lactamase in carbapenam resistant Acinetobacter baumannii (in Korean). Korean J Lab Med 2008; 28 (1): 16–23.
  • Amudhan SM, Sekar U, Arunagiri K, Sekar B. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian J Med Microbiol 2011; 29 (3): 269–74.
  • Karunasagar A, Maiti B, Shekar M, Shenoy MS, Karunasagar I. Prevalance of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. Microbiol Immunol 2011; 55 (4): 239–46.
  • Susan B, Amyes S. OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 2006; 57 (1): 1–3.
  • Yang HY, Lee HJ, Suh JT, Lee KM. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23p-lactamases in a tertiary care hospital in Korea. Yonsei Med J 2009; 50 (6): 764–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.